Literature DB >> 24565705

The diverse clinical features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome).

Solrun Melkorka Maggadottir1, Kathleen E Sullivan2.   

Abstract

A 2-year-old boy with chromosome 22q11.2 deletion syndrome was referred for recurrent sinopulmonary infections. He was diagnosed shortly after birth by a fluorescence in situ hybridization test that was performed due to interrupted aortic arch type B. He had no hypocalcemia, and his recovery from cardiac repair was uneventful. He had difficulty feeding and gained weight slowly, but, otherwise, there were no concerns during his first year of life. At 15 months of age, he began to develop significant otitis media and bronchitis. He was hospitalized once for pneumonia at 18 months of age and has never been off antibiotics for more than 1 week since then. He has not had any previous immunologic evaluation. Recurrent sinopulmonary infections in a child with chromosome 22q11.2 deletion syndrome can have the same etiologies as in any other child. Atopy, anatomic issues, cystic fibrosis, and new environmental exposures could be considered in this setting. Early childhood can be problematic for patients with chromosome 22q11.2 deletion syndrome due to unfavorable drainage of the middle ear and sinuses. Atopy occurs at a higher frequency in 22q11.2 deletion syndrome, and these children also have a higher rate of gastroesophageal reflux and aspiration than the general population. As would be appropriate for any child who presents with recurrent infections at 2 years of age, an immunologic evaluation should be performed. In this review, we will highlight recent findings and new data on the management of children and adults with chromosome 22q11.2 deletion syndrome.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  22q11.2; DiGeorge; Infection

Mesh:

Year:  2013        PMID: 24565705     DOI: 10.1016/j.jaip.2013.08.003

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  18 in total

1.  Spectrum of Clinical and Associated MR Imaging Findings in Children with Olfactory Anomalies.

Authors:  T N Booth; N K Rollins
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-17       Impact factor: 3.825

2.  Primary Immunodeficiency Diseases in Aguascalientes, Mexico: Results from an Educational Program.

Authors:  Aristoteles Alvarez-Cardona; Sara Elva Espinosa-Padilla; Saul Oswaldo Lugo Reyes; Javier Ventura-Juarez; Jaime Asael Lopez-Valdez; Lucila Martínez-Medina; Alberto Santillan-Artolozaga; Adriana Cajero-Avelar; Alma R De Luna-Sosa; Luis F Torres-Bernal; Francisco J Espinosa-Rosales
Journal:  J Clin Immunol       Date:  2016-02-22       Impact factor: 8.317

3.  Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency.

Authors:  Jessica C Barry; Terrence Blaine Crowley; Soma Jyonouchi; Jennifer Heimall; Elaine H Zackai; Kathleen E Sullivan; Donna M McDonald-McGinn
Journal:  J Clin Immunol       Date:  2017-05-24       Impact factor: 8.317

4.  Incomplete penetrance for isolated congenital asplenia in humans with mutations in translated and untranslated RPSA exons.

Authors:  Alexandre Bolze; Bertrand Boisson; Barbara Bosch; Alexander Antipenko; Matthieu Bouaziz; Paul Sackstein; Malik Chaker-Margot; Vincent Barlogis; Tracy Briggs; Elena Colino; Aurora C Elmore; Alain Fischer; Ferah Genel; Angela Hewlett; Maher Jedidi; Jadranka Kelecic; Renate Krüger; Cheng-Lung Ku; Dinakantha Kumararatne; Alain Lefevre-Utile; Sam Loughlin; Nizar Mahlaoui; Susanne Markus; Juan-Miguel Garcia; Mathilde Nizon; Matias Oleastro; Malgorzata Pac; Capucine Picard; Andrew J Pollard; Carlos Rodriguez-Gallego; Caroline Thomas; Horst Von Bernuth; Austen Worth; Isabelle Meyts; Maurizio Risolino; Licia Selleri; Anne Puel; Sebastian Klinge; Laurent Abel; Jean-Laurent Casanova
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-02       Impact factor: 11.205

Review 5.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

6.  Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection.

Authors:  Tsukasa Nabekura; Zhiying Chen; Casey Schroeder; Taeju Park; Eric Vivier; Lewis L Lanier; Dongfang Liu
Journal:  J Immunol       Date:  2018-04-04       Impact factor: 5.422

7.  22q and two: 22q11.2 deletion syndrome and coexisting conditions.

Authors:  Jennifer L Cohen; Terrence B Crowley; Daniel E McGinn; Carey McDougall; Marta Unolt; Michele P Lambert; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-09-23       Impact factor: 2.802

Review 8.  22q11 deletion syndrome: current perspective.

Authors:  Bülent Hacıhamdioğlu; Duygu Hacıhamdioğlu; Kenan Delil
Journal:  Appl Clin Genet       Date:  2015-05-18

9.  Failure to thrive as presentation in a patient with 22q11.2 microdeletion.

Authors:  Grazia Bossi; Chiara Gertosio; Cristina Meazza; Giovanni Farello; Mauro Bozzola
Journal:  Ital J Pediatr       Date:  2016-02-11       Impact factor: 2.638

Review 10.  The genetic landscape and clinical implications of vertebral anomalies in VACTERL association.

Authors:  Yixin Chen; Zhenlei Liu; Jia Chen; Yuzhi Zuo; Sen Liu; Weisheng Chen; Gang Liu; Guixing Qiu; Philip F Giampietro; Nan Wu; Zhihong Wu
Journal:  J Med Genet       Date:  2016-04-15       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.